Assignee
EMD LEXIGEN RES CT CORP
US·13 granted patents·5 pending applications·1,129 citations·filing 2000–2006
Top patents by PatentIndex Score
18 records- 0199US6617135B1Multiple cytokine protein complexesEMD LEXIGEN RES CT CORP·Filed 2000·Granted Sep 9, 2003·211 cites·17 claims
- 0298US7186804B2IL-2 fusion proteins with modulated selectivityEMD LEXIGEN RES CT CORP·Filed 2002·Granted Mar 6, 2007·140 cites·23 claims
- 0398US7148321B2Expression technology for proteins containing a hybrid isotype antibody moietyEMD LEXIGEN RES CT CORP·Filed 2002·Granted Dec 12, 2006·114 cites·10 claims
- 0498US7091321B2Enhancing the circulating half-life of antibody-based fusion proteinsEMD LEXIGEN RES CT CORP·Filed 2001·Granted Aug 15, 2006·133 cites·31 claims
- 0598US6992174B2Reducing the immunogenicity of fusion proteinsEMD LEXIGEN RES CT CORP·Filed 2002·Granted Jan 31, 2006·94 cites·2 claims
- 0697US7067110B1Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigensEMD LEXIGEN RES CT CORP·Filed 2000·Granted Jun 27, 2006·110 cites·25 claims
- 0796US7169904B2Immunocytokine sequences and uses thereofEMD LEXIGEN RES CT CORP·Filed 2003·Granted Jan 30, 2007·46 cites·5 claims
- 0896US6838260B2Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulationEMD LEXIGEN RES CT CORP·Filed 2001·Granted Jan 4, 2005·78 cites·8 claims
- 0994US7226998B2Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulationEMD LEXIGEN RES CT CORP·Filed 2004·Granted Jun 5, 2007·35 cites·8 claims
- 1094US7141651B2Multiple cytokine protein complexesEMD LEXIGEN RES CT CORP·Filed 2003·Granted Nov 28, 2006·50 cites·29 claims
- 1194US6969517B2Recombinant tumor specific antibody and use thereofEMD LEXIGEN RES CT CORP·Filed 2002·Granted Nov 29, 2005·54 cites·5 claims
- 1292US7323549B2IL-7 fusion proteinsEMD LEXIGEN RES CT CORP·Filed 2004·Granted Jan 29, 2008·50 cites·17 claims
- 1382US7115261B1Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapiesEMD LEXIGEN RES CT CORP·Filed 2000·Granted Oct 3, 2006·14 cites·14 claims
- 1457US2006194952A1Enhancing the circulating half-life of antibody-based fusion proteinsEMD LEXIGEN RES CT CORP·Filed 2006·Application pending·0 cites
- 1554US2005069521A1Enhancing the circulating half-life of interleukin-2 proteinsEMD LEXIGEN RES CT CORP·Filed 2004·Application pending·0 cites
- 1653US2005042729A1Expression and export of interferon-alpha proteins as Fc fusion proteinsEMD LEXIGEN RES CT CORP·Filed 2004·Application pending·0 cites
- 1752US2004033210A1Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitorEMD LEXIGEN RES CT CORP·Filed 2003·Application pending·0 cites
- 1846US2004180035A1IL-15 immunoconjugates and uses thereofEMD LEXIGEN RES CT CORP·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EMD LEXIGEN RES CT CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →